MAPT and Parkinson disease: It is plausible that hyperactivity of pathogenic LRRK2 plays a role in neurodegeneration by disturbing microtubule dynamics, but future studies are needed to investigate if LRRK2 phosphorylates tubulin and tau in vivo and whether and how the phosphorylation events contribute to PD pathology.